open_comments_active (view)
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
1,133 rows
This data as json, CSV (advanced)
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | comment_end_datetime | perpetual_docket | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IRS-2025-0013-0001 | IRS | IRS-2025-0013 | Announcement 2025-6 | Notice | Announcement | 2025-01-15 | 2025 | 1 | 2025-01-15 | 2027-01-15 | 2027-01-16 04:59:59 | 0 | 2025-10-13 09:00:11 | 1 | 0 | 09000064868c30ce | |
| HHS-OPHS-2018-0025-0001 | HHS | HHS-OPHS-2018-0025 | Posting Requirement for the Exemption at 45 CFR 46.104(d)(5) of the 2018 Requirements (2022) | Other | 2022-06-15 | 2022 | 6 | 2022-06-27 | 2032-06-30 | 2032-07-01 03:59:59 | 0 | 2026-04-27 09:00:11 | 1 | 0 | 0900006485164c0a | ||
| EPA-HQ-OPP-2023-0288-0008 | EPA | EPA-HQ-OPP-2023-0288 | Guidance: Pesticides; Evaluation of Products for Claims against Viruses | Notice | 2024-10-10 | 2024 | 10 | 2024-10-10 | 2032-10-10 | 2032-10-11 03:59:59 | 0 | 2026-05-07 09:00:17 | 2024-23471 | 1 | 0 | 09000064867c4202 | |
| FDA-2011-N-0655-0041 | FDA | FDA-2011-N-0655 | Animal Generic Drug User Fee Act; Public Meeting; Request for Comments | Notice | Request for Comments | 2026-04-17 | 2026 | 4 | 2026-04-17 | 2027-12-01 | 2027-12-02 04:59:59 | 0 | 2026-07-01 09:00:24 | 2026-07497 | 1 | 0 | 09000064b928930a |
| FDA-2026-N-0131-0001 | FDA | FDA-2026-N-0131 | FDA Rare Disease Innovation Hub Future Programming; Request for Comments | Notice | Request for Comments | 2026-01-30 | 2026 | 1 | 2026-01-30 | 2026-12-31 | 2027-01-01 04:59:59 | 0 | 2026-07-08 09:00:11 | 2026-01903 | 1 | 0 | 09000064b91893ee |
| FHWA-2026-0826-0001 | FHWA | FHWA-2026-0826 | Environmental Impact Statements; Availability, etc.: Washington County, ME | Notice | Notice of Intent | 2026-07-09 | 2026 | 7 | 2026-07-09 | 2026-10-31 | 2026-11-01 03:59:59 | 0 | 2026-07-09 17:07:02 | 2026-13876 | 1 | 0 | 09000064b9376458 |
| FAA-2026-7210-0001 | FAA | FAA-2026-7210 | Intent to Designate as Abandoned: Abandoned Javelin Conversions, Inc. Supplemental Type Certificates | Notice | Request for Comments | 2026-07-08 | 2026 | 7 | 2026-07-08 | 2027-01-04 | 2027-01-05 04:59:59 | 0 | 2026-07-14 09:00:28 | 2026-13723 | 1 | 0 | 09000064b9370750 |
| FDA-2026-N-7864-0001 | FDA | FDA-2026-N-7864 | Data Request (DR001): Use of the pH Cycling Test Model as a Testing Procedure for Fluoride Dentifrice Drug Products in Over-the-Counter (OTC) Monograph M021: Anticaries Drug Products for Over-the-Counter Human Use | Other | Request | 2026-07-28 | 2026 | 7 | 2026-07-28 | 2027-01-25 | 2027-01-26 04:59:59 | 0 | 2026-07-28 16:50:16 | 1 | 0 | 09000064b93c7444 | |
| NCUA-2026-1420-0001 | NCUA | NCUA-2026-1420 | Great Horizons Federal Credit Union - Disclaimer | Notice | 2026-07-29 | 2026 | 7 | 2026-08-05 | 2026-10-08 | 2026-10-09 03:59:59 | 0 | 2026-07-29 19:40:35 | 1 | 0 | 09000064b93d6ce0 | ||
| ITC-2026-4258-0001 | ITC | Investigations; Determinations, Modifications, and Rulings, etc.: Certain Seamless Carbon and Alloy Steel Standard, Line, and Pressure Pipe from China | Notice | 2026-08-03 | 2026 | 8 | 2026-08-03 | 2026-10-16 | 2026-10-17 03:59:59 | 0 | 2026-08-03 16:26:42 | 2026-15646 | 1 | 0 | 09000064b93e9d48 | ||
| BIA-2022-0005-0024 | BIA | BIA-2022-0005 | Agency Information Collection Activities; Education Contracts Under the Johnson-O'Malley Act | Notice | 2026-01-22 | 2026 | 1 | 2026-01-21 | 2027-03-31 | 2027-04-01 03:59:59 | 0 | 2026-08-04 23:28:41 | 2026-01179 | 1 | 0 | 09000064b9179f6a | |
| IRS-2026-0496-0001 | IRS | IRS-2026-0496 | Guidance on the employer credit for paid family and medical leave under section 45S (Notice 2026-28) | Notice | Notice of Publication | 2026-08-05 | 2026 | 8 | 2026-08-05 | 2026-10-16 | 2026-10-17 03:59:59 | 0 | 2026-08-05 19:40:14 | 1 | 0 | 09000064b940001a | |
| FCC-2026-3072-0001 | FCC | Build America: Eliminating Barriers to Wireline Deployments | Proposed Rule | 2026-08-07 | 2026 | 8 | 2026-08-07 | 2026-11-05 | 2026-11-06 04:59:59 | 0 | 2026-08-07 16:26:39 | 2026-16196 | 1 | 0 | 09000064b9416ef1 | ||
| FDA-2025-E-0707-0005 | FDA | FDA-2025-E-0707 | Determination of Regulatory Review Period for Purposes of Patent Extension; DAYVIGO | Notice | Determinations | 2026-08-10 | 2026 | 8 | 2026-08-10 | 2026-10-09 | 2026-10-10 03:59:59 | 0 | 2026-08-10 17:44:43 | 2026-16246 | 1 | 0 | 09000064b94289c5 |
| FCC-2026-3137-0001 | FCC | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | 2026-08-11 | 2026 | 8 | 2026-08-11 | 2026-10-13 | 2026-10-14 03:59:59 | 0 | 2026-08-11 16:26:39 | 2026-16298 | 1 | 0 | 09000064b942eb47 | ||
| EPA-HQ-OPPT-2015-0436-0048 | EPA | EPA-HQ-OPPT-2015-0436 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Generic Clearance for TSCA Section 4 Test Rules, Test Orders, Enforceable Consent Agreements, Voluntary Data Submissions, and Exemptions from Testing Requirement (Renewal) | Notice | Information Collection Request (ICR) | 2026-08-11 | 2026 | 8 | 2026-08-11 | 2026-10-13 | 2026-10-14 03:59:59 | 0 | 2026-08-11 16:45:13 | 2026-16311 | 1 | 0 | 09000064b942eba1 |
| NARA_FRDOC_0001-1137 | NARA | NARA_FRDOC_0001 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | 2026-08-12 | 2026 | 8 | 2026-08-12 | 2026-10-13 | 2026-10-14 03:59:59 | 0 | 2026-08-12 16:25:45 | 2026-16378 | 1 | 0 | 09000064b9436a4c | |
| CMS-2026-2740-0001 | CMS | CMS-2026-2740 | Electronic Funds Transfer Authorization Agreement (CMS-588) | Notice | 2026-08-12 | 2026 | 8 | 2026-08-12 | 2026-10-13 | 2026-10-14 03:59:59 | 0 | 2026-08-12 18:14:49 | 2026-16386 | 1 | 0 | 09000064b9436ab0 | |
| NCUA-2026-1520-0001 | NCUA | NCUA-2026-1520 | NRS Community Development Federal Credit Union - Disclaimer | Notice | 2026-08-12 | 2026 | 8 | 2026-08-31 | 2026-11-08 | 2026-11-09 04:59:59 | 0 | 2026-08-12 19:09:32 | 1 | 0 | 09000064b9437da7 | ||
| FDA-2011-N-0656-1315 | FDA | FDA-2011-N-0656 | Animal Drug User Fee Act; Stakeholder Consultation Meetings on the Animal Drug User Fee Act Reauthorization; Request for Notification of Stakeholder Intent To Participate | Notice | General Notice | 2026-05-11 | 2026 | 5 | 2026-05-11 | 2027-12-01 | 2027-12-02 04:59:59 | 0 | 2026-08-13 14:40:33 | 2026-09283 | 1 | 0 | 09000064b92cacd0 |
| FDA-2011-N-0655-0042 | FDA | FDA-2011-N-0655 | Animal Generic Drug User Fee Act; Stakeholder Consultation Meetings on the Animal Generic Drug User Fee Act Reauthorization; Request for Notification of Stakeholder Intent To Participate | Notice | Notice of Intent | 2026-05-11 | 2026 | 5 | 2026-05-11 | 2027-12-01 | 2027-12-02 04:59:59 | 0 | 2026-08-13 14:41:39 | 2026-09284 | 1 | 0 | 09000064b92cf91b |
| CMS-2026-2773-0001 | CMS | CMS-2026-2773 | Quality Bonus Payment Appeals (CMS-10346) | Notice | 2026-08-13 | 2026 | 8 | 2026-08-13 | 2026-10-13 | 2026-10-14 03:59:59 | 0 | 2026-08-13 19:28:46 | 2026-16455 | 1 | 0 | 09000064b943bb72 | |
| USA-2026-HQ-0562-0001 | USA | USA-2026-HQ-0562 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | 2026-08-13 | 2026 | 8 | 2026-08-13 | 2026-10-13 | 2026-10-14 03:59:59 | 0 | 2026-08-14 17:18:13 | 2026-16530 | 1 | 0 | 09000064b9436b87 | |
| FCC-2026-3202-0001 | FCC | Review of E-Rate Program to Ensure Congress's Vision | Proposed Rule | 2026-08-14 | 2026 | 8 | 2026-08-14 | 2026-11-12 | 2026-11-13 04:59:59 | 0 | 2026-08-14 19:25:18 | 2026-16590 | 1 | 0 | 09000064b945712e | ||
| FCC-2026-3203-0001 | FCC | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | 2026-08-14 | 2026 | 8 | 2026-08-14 | 2026-10-13 | 2026-10-14 03:59:59 | 0 | 2026-08-14 19:25:21 | 2026-16556 | 1 | 0 | 09000064b9457132 | ||
| FS_FRDOC_0001-4420 | FS | FS_FRDOC_0001 | Requests for Nominations: Secure Rural Schools Resource Advisory Committees | Notice | 2026-08-14 | 2026 | 8 | 2026-08-14 | 2026-11-12 | 2026-11-13 04:59:59 | 0 | 2026-08-14 19:25:23 | 2026-16656 | 1 | 0 | 09000064b94571f5 | |
| CFTC-2026-1783-0001 | CFTC | CFTC-2026-1783 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | 2026-08-14 | 2026 | 8 | 2026-08-14 | 2026-10-13 | 2026-10-14 03:59:59 | 0 | 2026-08-14 19:25:25 | 2026-16631 | 1 | 0 | 09000064b94572fd | |
| FERC-2026-4828-0001 | FERC | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | 2026-08-14 | 2026 | 8 | 2026-08-14 | 2026-10-13 | 2026-10-14 03:59:59 | 0 | 2026-08-14 19:25:25 | 2026-16653 | 1 | 0 | 09000064b9457392 | ||
| FRA-2026-1585-0001 | FRA | FRA-2026-1585 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | Request for Comments | 2026-08-14 | 2026 | 8 | 2026-08-14 | 2026-10-13 | 2026-10-14 03:59:59 | 0 | 2026-08-14 19:25:25 | 2026-16593 | 1 | 0 | 09000064b9457347 |
| FRA-2026-0039-0001 | FRA | FRA-2026-0039 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | Request for Comments | 2026-08-14 | 2026 | 8 | 2026-08-14 | 2026-10-13 | 2026-10-14 03:59:59 | 0 | 2026-08-14 19:31:03 | 2026-16592 | 1 | 0 | 09000064b944e8ab |
| EPA-HQ-OPPT-2025-2433-0001 | EPA | EPA-HQ-OPPT-2025-2433 | 2026 Unified Agenda of Regulatory and Deregulatory Actions | Notice | 2026-08-14 | 2026 | 8 | 2026-08-14 | 2026-10-13 | 2026-10-14 03:59:59 | 0 | 2026-08-15 09:01:35 | 2026-16608 | 1 | 0 | 09000064b9457348 | |
| VA-2026-VACO-0001-0328 | VA | VA-2026-VACO-0001 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Application for Assumption Approval and/or Release from Personal Liability to the Government on a Home Loan [FR Doc No: 2026-16501; OMB Control No. 2900-0110] | Notice | 2026-08-13 | 2026 | 8 | 2026-08-13 | 2026-10-13 | 2026-10-14 03:59:59 | 0 | 2026-08-17 09:00:53 | 2026-16501 | 1 | 0 | 09000064b943bb78 | |
| VA-2026-VACO-0001-0329 | VA | VA-2026-VACO-0001 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Mandatory Verification of Dependents [FR Doc No: 2026-16500; OMB Control No. 2900-0500] | Notice | 2026-08-13 | 2026 | 8 | 2026-08-13 | 2026-10-13 | 2026-10-14 03:59:59 | 0 | 2026-08-17 09:00:53 | 2026-16500 | 1 | 0 | 09000064b9436b88 | |
| FISCAL_FRDOC_0001-0309 | FISCAL | FISCAL_FRDOC_0001 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Annual Financial Statement of Surety Companies—Schedule F | Notice | 2026-08-17 | 2026 | 8 | 2026-08-17 | 2026-10-16 | 2026-10-17 03:59:59 | 0 | 2026-08-17 16:25:56 | 2026-16725 | 1 | 0 | 09000064b9462d0d | |
| FISCAL_FRDOC_0001-0310 | FISCAL | FISCAL_FRDOC_0001 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Authorization Agreement for Preauthorized Payment | Notice | 2026-08-17 | 2026 | 8 | 2026-08-17 | 2026-10-16 | 2026-10-17 03:59:59 | 0 | 2026-08-17 16:26:07 | 2026-16726 | 1 | 0 | 09000064b9462d58 | |
| NHTSA-2026-1651-0001 | NHTSA | NHTSA-2026-1651 | New Car Assessment Program: Removal of Dynamic Rollover Resistance Test and Side Air Bag Out-of-Position Testing; Updates to NCAP's 10-Year Roadmap | Notice | Request for Comments | 2026-08-17 | 2026 | 8 | 2026-08-17 | 2026-10-16 | 2026-10-17 03:59:59 | 0 | 2026-08-17 16:36:20 | 2026-16735 | 1 | 0 | 09000064b9461c63 |
| FDA-2026-N-7757-0001 | FDA | FDA-2026-N-7757 | Agency Information Collection Activities; Proposed Collection; Comment Request; Third Party Disclosure and Recordkeeping Requirements for Reportable Food | Notice | 60 Day Proposed Information Collection | 2026-08-17 | 2026 | 8 | 2026-08-17 | 2026-10-16 | 2026-10-17 03:59:59 | 0 | 2026-08-17 17:13:22 | 2026-16714 | 1 | 0 | 09000064b9462da6 |
| FDA-2026-N-8328-0001 | FDA | FDA-2026-N-8328 | Agency Information Collection Activities; Proposed Collection; Comment Request; Imports and Electronic Import Entries | Notice | 60 Day Proposed Information Collection | 2026-08-17 | 2026 | 8 | 2026-08-17 | 2026-10-16 | 2026-10-17 03:59:59 | 0 | 2026-08-17 17:48:14 | 2026-16712 | 1 | 0 | 09000064b9462da4 |
| FDA-2025-E-0490-0005 | FDA | FDA-2025-E-0490 | Determination of Regulatory Review Period for Purposes of Patent Extension; BIZENGRI | Notice | Determinations | 2026-08-17 | 2026 | 8 | 2026-08-17 | 2026-10-16 | 2026-10-17 03:59:59 | 0 | 2026-08-17 18:05:29 | 2026-16713 | 1 | 0 | 09000064b9462d5b |
| FDA-2025-E-0485-0005 | FDA | FDA-2025-E-0485 | Determination of Regulatory Review Period for Purposes of Patent Extension; BIZENGRI | Notice | Determinations | 2026-08-17 | 2026 | 8 | 2026-08-17 | 2026-10-16 | 2026-10-17 03:59:59 | 0 | 2026-08-17 18:06:12 | 2026-16713 | 1 | 0 | 09000064b9463d3f |
| FDA-2025-E-0486-0005 | FDA | FDA-2025-E-0486 | Determination of Regulatory Review Period for Purposes of Patent Extension; BIZENGRI | Notice | Determinations | 2026-08-17 | 2026 | 8 | 2026-08-17 | 2026-10-16 | 2026-10-17 03:59:59 | 0 | 2026-08-17 18:06:44 | 2026-16713 | 1 | 0 | 09000064b9463d40 |
| FDA-2025-E-0488-0005 | FDA | FDA-2025-E-0488 | Determination of Regulatory Review Period for Purposes of Patent Extension; BIZENGRI | Notice | Determinations | 2026-08-17 | 2026 | 8 | 2026-08-17 | 2026-10-16 | 2026-10-17 03:59:59 | 0 | 2026-08-17 18:07:20 | 2026-16713 | 1 | 0 | 09000064b9463d41 |
| FDA-2025-E-0489-0005 | FDA | FDA-2025-E-0489 | Determination of Regulatory Review Period for Purposes of Patent Extension; BIZENGRI | Notice | Determinations | 2026-08-17 | 2026 | 8 | 2026-08-17 | 2026-10-16 | 2026-10-17 03:59:59 | 0 | 2026-08-17 18:07:39 | 2026-16713 | 1 | 0 | 09000064b9463d42 |
| OPM-2026-0134-0042 | OPM | OPM-2026-0134 | Privacy Act; Re-Established Matching Program | Notice | 2026-08-06 | 2026 | 8 | 2026-08-06 | 2026-10-27 | 2026-10-28 03:59:59 | 0 | 2026-08-17 18:58:03 | 2026-15940 | 1 | 0 | 09000064b9407cd1 | |
| DARS-2026-0364-0001 | DARS | DARS-2026-0364 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Defense Federal Acquisition Regulation Supplement, DoD Mentor-Protege Program | Notice | 2026-08-17 | 2026 | 8 | 2026-08-17 | 2026-10-16 | 2026-10-17 03:59:59 | 0 | 2026-08-17 19:11:31 | 2026-16682 | 1 | 0 | 09000064b9462d14 | |
| DEA-2022-0002-0008 | DEA | DEA-2022-0002 | Exempt Chemical Preparations Aug 2026 (2026-16665) - DEA372 | Notice | 2026-08-17 | 2026 | 8 | 2026-08-17 | 2026-10-13 | 2026-10-14 03:59:59 | 0 | 2026-08-17 21:26:45 | 2026-16665 | 1 | 0 | 09000064b946485f | |
| BOEM-2026-0926-0001 | BOEM | BOEM-2026-0926 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Negotiated Noncompetitive Agreements for the Use of Outer Continental Shelf Sand, Gravel, and/or Shell Resources | Notice | 2026-08-17 | 2026 | 8 | 2026-08-17 | 2026-10-16 | 2026-10-17 03:59:59 | 0 | 2026-08-18 09:01:12 | 2026-16684 | 1 | 0 | 09000064b9461cb0 | |
| USBC-2026-0430-0001 | USBC | USBC-2026-0430 | CoG 60dayfrn_published_081826 | Notice | 2026-08-18 | 2026 | 8 | 2026-08-18 | 2026-10-18 | 2026-10-19 03:59:59 | 0 | 2026-08-18 17:03:09 | 2026-16791 | 1 | 0 | 09000064b9467195 | |
| FDA-2017-D-5974-0012 | FDA | FDA-2017-D-5974 | Determining Whether To Submit an ANDA or a 505(b)(2) Application; Draft Guidance for Industry; Availability | Notice | Determinations | 2026-08-18 | 2026 | 8 | 2026-08-18 | 2026-10-19 | 2026-10-20 03:59:59 | 0 | 2026-08-18 17:24:50 | 2026-16837 | 1 | 0 | 09000064b9467538 |
| FDA-2026-N-7914-0001 | FDA | FDA-2026-N-7914 | Public Meeting on Listeria monocytogenes Prevention | Other | Additional Information | 2026-08-03 | 2026 | 8 | 2026-08-03 | 2026-11-02 | 2026-11-03 04:59:59 | 0 | 2026-08-19 09:01:12 | 1 | 0 | 09000064b93e5b66 | |
| FDIC-2026-1486-0001 | FDIC | Community Reinvestment Act Regulations | Proposed Rule | 2026-08-12 | 2026 | 8 | 2026-08-12 | 2026-10-13 | 2026-10-14 03:59:59 | 0 | 2026-08-19 16:25:21 | 2026-16454 | 1 | 0 | 09000064b9436b80 | ||
| DOL_FRDOC_0001-2697 | DOL | DOL_FRDOC_0001 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | 2026-08-19 | 2026 | 8 | 2026-08-19 | 2026-10-19 | 2026-10-20 03:59:59 | 0 | 2026-08-19 16:39:59 | 2026-16880 | 1 | 0 | 09000064b946a963 | |
| OPM_FRDOC_0001-4615 | OPM | OPM_FRDOC_0001 | Privacy Act; Matching Program | Notice | 2026-08-19 | 2026 | 8 | 2026-08-19 | 2026-10-20 | 2026-10-21 03:59:59 | 0 | 2026-08-19 16:40:05 | 2026-16849 | 1 | 0 | 09000064b946a998 | |
| DOD-2026-OS-1684-0001 | DOD | DOD-2026-OS-1684 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | 2026-08-19 | 2026 | 8 | 2026-08-19 | 2026-10-19 | 2026-10-20 03:59:59 | 0 | 2026-08-19 18:36:14 | 2026-16920 | 1 | 0 | 09000064b946a9d7 | |
| FDA-2011-N-0656-1314 | FDA | FDA-2011-N-0656 | Animal Drug User Fee Act; Public Meeting; Request for Comments | Notice | Request for Comments | 2026-04-17 | 2026 | 4 | 2026-04-17 | 2027-12-01 | 2027-12-02 04:59:59 | 0 | 2026-08-20 09:01:12 | 2026-07498 | 1 | 0 | 09000064b928948d |
| EIB-2026-0232-0001 | EIB | EIB-2026-0232 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Notice of Claim and Proof of Loss, Working Capital Guarantee | Notice | 2026-08-18 | 2026 | 8 | 2026-08-18 | 2026-10-19 | 2026-10-20 03:59:59 | 0 | 2026-08-20 09:01:26 | 2026-16845 | 1 | 0 | 09000064b94653e1 | |
| AMS-NOP-26-1321-0001 | AMS | AMS-NOP-26-1321 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: National Organic Program; Strengthening Organic Enforcement | Notice | 60 Day Proposed Information Collection | 2026-08-19 | 2026 | 8 | 2026-08-19 | 2026-10-19 | 2026-10-20 03:59:59 | 0 | 2026-08-20 09:01:27 | 2026-16910 | 1 | 0 | 09000064b946aa25 |
| FCC-2026-3268-0001 | FCC | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | 2026-08-20 | 2026 | 8 | 2026-08-20 | 2026-10-19 | 2026-10-20 03:59:59 | 0 | 2026-08-20 16:26:27 | 2026-16993 | 1 | 0 | 09000064b946aac1 | ||
| STB-2026-2312-0001 | STB | Control: Union Pacific Corp. and Union Pacific Railroad Co., Norfolk Southern Corp. and Norfolk Southern Railway Co. | Notice | 2026-08-20 | 2026 | 8 | 2026-08-20 | 2027-03-29 | 2027-03-30 03:59:59 | 0 | 2026-08-20 16:26:53 | 2026-17024 | 1 | 0 | 09000064b946c86d | ||
| FCC-2026-3270-0001 | FCC | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | 2026-08-20 | 2026 | 8 | 2026-08-20 | 2026-10-19 | 2026-10-20 03:59:59 | 0 | 2026-08-20 16:27:26 | 2026-16996 | 1 | 0 | 09000064b946c8b7 | ||
| FCC-2026-3271-0001 | FCC | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | 2026-08-20 | 2026 | 8 | 2026-08-20 | 2026-10-19 | 2026-10-20 03:59:59 | 0 | 2026-08-20 16:27:51 | 2026-16997 | 1 | 0 | 09000064b946e17f | ||
| NSF_FRDOC_0001-3629 | NSF | NSF_FRDOC_0001 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Improving Customer Experience | Notice | 2026-08-20 | 2026 | 8 | 2026-08-20 | 2026-10-19 | 2026-10-20 03:59:59 | 0 | 2026-08-20 16:27:53 | 2026-16984 | 1 | 0 | 09000064b946e1c2 | |
| FDA-2026-D-8561-0001 | FDA | FDA-2026-D-8561 | Potency Assessment of Active Immunotherapy Products; Draft Guidance for Industry; Availability | Notice | Notice of Availability | 2026-08-20 | 2026 | 8 | 2026-08-20 | 2026-11-18 | 2026-11-19 04:59:59 | 0 | 2026-08-20 17:54:40 | 2026-16960 | 1 | 0 | 09000064b946c7f3 |
| FDA-2026-D-8561-0002 | FDA | FDA-2026-D-8561 | Potency Assessment of Active Immunotherapy Products; Draft Guidance for Industry | Other | Guidance | 2026-08-20 | 2026 | 8 | 2026-08-20 | 2026-11-18 | 2026-11-19 04:59:59 | 0 | 2026-08-20 17:59:44 | 1 | 0 | 09000064b946ee4d | |
| FCC-2026-3301-0001 | FCC | Radio Broadcasting Services: AM or FM Proposals to Change the Community of License | Notice | 2026-08-21 | 2026 | 8 | 2026-08-21 | 2026-10-20 | 2026-10-21 03:59:59 | 0 | 2026-08-21 16:25:50 | 2026-17160 | 1 | 0 | 09000064b9473727 | ||
| SEC-2026-5190-0001 | SEC | Regulation Crypto Assets | Proposed Rule | 2026-08-21 | 2026 | 8 | 2026-08-21 | 2026-10-20 | 2026-10-21 03:59:59 | 0 | 2026-08-21 16:27:47 | 2026-17183 | 1 | 0 | 09000064b94738fa | ||
| RITA-2026-0001-0001 | RITA | RITA-2026-0001 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Intermodal Freight Facilities Air-to-Truck and Mail Cargo Geospatial Data Update | Notice | Request for Comments | 2026-08-20 | 2026 | 8 | 2026-08-20 | 2026-10-19 | 2026-10-20 03:59:59 | 0 | 2026-08-21 16:27:55 | 2026-17000 | 1 | 0 | 09000064b946e138 |
| FEMA-2026-0002-0051 | FEMA | FEMA-2026-0002 | Proposed Flood Hazard Determinations | Notice | 2026-08-21 | 2026 | 8 | 2026-08-21 | 2026-11-19 | 2026-11-20 04:59:59 | 0 | 2026-08-21 17:01:46 | 2026-17076 | 1 | 0 | 09000064b94736f1 | |
| FEMA-2026-0002-0053 | FEMA | FEMA-2026-0002 | Proposed Flood Hazard Determinations | Notice | 2026-08-21 | 2026 | 8 | 2026-08-21 | 2026-11-19 | 2026-11-20 04:59:59 | 0 | 2026-08-21 17:04:23 | 2026-17075 | 1 | 0 | 09000064b94736f4 | |
| OSHA-2012-0005-0016 | OSHA | OSHA-2012-0005 | Cadmium in General Industry Standard; Extension of the Office of Management and Budget’s (OMB) Approval of Information Collection (Paperwork) Requirements | Notice | Request for Comments | 2026-08-21 | 2026 | 8 | 2026-08-21 | 2026-10-20 | 2026-10-21 03:59:59 | 0 | 2026-08-21 17:09:23 | 2026-17151 | 1 | 0 | 09000064b94737b7 |
| FEMA-2026-0002-0056 | FEMA | FEMA-2026-0002 | Proposed Flood Hazard Determinations | Notice | 2026-08-21 | 2026 | 8 | 2026-08-21 | 2026-11-19 | 2026-11-20 04:59:59 | 0 | 2026-08-21 17:09:32 | 2026-17074 | 1 | 0 | 09000064b9473724 | |
| BOEM-2026-0958-0001 | BOEM | BOEM-2026-0958 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Application to be Recognized as Qualified to Bid on, Hold, or Operate a Lease or Grant on the Outer Continental Shelf | Notice | 2026-08-21 | 2026 | 8 | 2026-08-21 | 2026-10-20 | 2026-10-21 03:59:59 | 0 | 2026-08-21 17:11:12 | 2026-17149 | 1 | 0 | 09000064b94738c2 | |
| EPA-HQ-OW-2014-0359-0042 | EPA | EPA-HQ-OW-2014-0359 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Information Request for the Underground Injection Control Program | Notice | Information Collection Request (ICR) | 2026-08-21 | 2026 | 8 | 2026-08-21 | 2026-10-20 | 2026-10-21 03:59:59 | 0 | 2026-08-21 17:53:22 | 2026-17096 | 1 | 0 | 09000064b94736ed |
| CISA-2026-0166-0001 | CISA | CISA-2026-0166 | Agency Information Collection Activities: The Department of Homeland Security, Emergency Communications Division, Communications Assets Survey and Mapping (CASM) Tool Registration Tool | Notice | 2026-08-19 | 2026 | 8 | 2026-08-19 | 2026-10-19 | 2026-10-20 03:59:59 | 0 | 2026-08-21 18:19:06 | 2026-16877 | 1 | 0 | 09000064b946a9df | |
| EPA-HQ-OPP-2022-0455-0011 | EPA | EPA-HQ-OPP-2022-0455 | Pesticide Tolerances: Carboxin | Rule | Final Rule | 2026-08-21 | 2026 | 8 | 2026-08-21 | 2026-10-20 | 2026-10-21 03:59:59 | 0 | 2026-08-21 18:39:46 | 2026-17088 | 1 | 0 | 09000064b94736ee |
| CMS-2026-2839-0001 | CMS | CMS-2026-2839 | Manufacturer Submission of Average Sales Price (ASP) Data for Medicare Part B Drugs and Biologicals and Supporting Regulations in 42 CFR 414.800-806 (CMS-10110) | Notice | 2026-08-21 | 2026 | 8 | 2026-08-21 | 2026-10-20 | 2026-10-21 03:59:59 | 0 | 2026-08-21 18:45:44 | 2026-17128 | 1 | 0 | 09000064b94736f2 | |
| EPA-HQ-OPP-2022-0743-0004 | EPA | EPA-HQ-OPP-2022-0743 | Pesticide Tolerance; Exemptions, Petitions, Revocations, etc.: Calcium Carbonate | Rule | 2026-08-17 | 2026 | 8 | 2026-08-17 | 2026-10-16 | 2026-10-17 03:59:59 | 0 | 2026-08-22 09:02:45 | 2026-16720 | 1 | 0 | 09000064b9461c65 | |
| CMS-2026-2872-0001 | CMS | CMS-2026-2872 | End Stage Renal Disease Medical Evidence Report Medicare Entitlement and/or Patient Registration (CMS-2728) | Notice | 2026-08-22 | 2026 | 8 | 2026-08-22 | 2026-10-20 | 2026-10-21 03:59:59 | 0 | 2026-08-22 18:47:51 | 2026-17128 | 1 | 0 | 09000064b94750de | |
| FAA-2026-8786-0001 | FAA | FAA-2026-8786 | Airworthiness Directives: Airbus Helicopters | Proposed Rule | Request for Comment | 2026-08-24 | 2026 | 8 | 2026-08-24 | 2026-10-08 | 2026-10-09 03:59:59 | 0 | 2026-08-24 16:54:53 | 2026-17209 | 1 | 0 | 09000064b948c1ef |
| FDA-2007-D-0369-2652 | FDA | FDA-2007-D-0369 | PSG_020816 - Draft Guidance on Brinzolamide | Other | Guidance | 2026-08-24 | 2026 | 8 | 2026-08-24 | 2026-10-23 | 2026-10-24 03:59:59 | 0 | 2026-08-24 20:08:40 | 1 | 0 | 09000064b9470607 | |
| FDA-2007-D-0369-2653 | FDA | FDA-2007-D-0369 | PSG_020732 - Draft Guidance on Buprenorphine | Other | Guidance | 2026-08-24 | 2026 | 8 | 2026-08-24 | 2026-10-23 | 2026-10-24 03:59:59 | 0 | 2026-08-24 20:08:45 | 1 | 0 | 09000064b94706ae | |
| FDA-2007-D-0369-2654 | FDA | FDA-2007-D-0369 | PSG_204370 - Draft Guidance on Cariprazine Hydrochloride | Other | Guidance | 2026-08-24 | 2026 | 8 | 2026-08-24 | 2026-10-23 | 2026-10-24 03:59:59 | 0 | 2026-08-24 20:08:55 | 1 | 0 | 09000064b94706b0 | |
| FDA-2007-D-0369-2655 | FDA | FDA-2007-D-0369 | PSG_050600 - Draft Guidance on Clindamycin Phosphate | Other | Guidance | 2026-08-24 | 2026 | 8 | 2026-08-24 | 2026-10-23 | 2026-10-24 03:59:59 | 0 | 2026-08-24 20:09:04 | 1 | 0 | 09000064b94706b2 | |
| FDA-2007-D-0369-2656 | FDA | FDA-2007-D-0369 | PSG_215425 - Draft Guidance on Epinephrine | Other | Guidance | 2026-08-24 | 2026 | 8 | 2026-08-24 | 2026-10-23 | 2026-10-24 03:59:59 | 0 | 2026-08-24 20:09:08 | 1 | 0 | 09000064b94706b4 | |
| FDA-2007-D-0369-2657 | FDA | FDA-2007-D-0369 | PSG_218475 - Draft Guidance on Epinephrine Bitartrate | Other | Guidance | 2026-08-24 | 2026 | 8 | 2026-08-24 | 2026-10-23 | 2026-10-24 03:59:59 | 0 | 2026-08-24 20:09:13 | 1 | 0 | 09000064b94706b6 | |
| FDA-2007-D-0369-2658 | FDA | FDA-2007-D-0369 | PSG_203565 - Draft Guidance on Ferric Carboxymaltose | Other | Guidance | 2026-08-24 | 2026 | 8 | 2026-08-24 | 2026-10-23 | 2026-10-24 03:59:59 | 0 | 2026-08-24 20:09:18 | 1 | 0 | 09000064b94706b8 | |
| FDA-2007-D-0369-2659 | FDA | FDA-2007-D-0369 | PSG_022180 - Draft Guidance on Ferumoxytol | Other | Guidance | 2026-08-24 | 2026 | 8 | 2026-08-24 | 2026-10-23 | 2026-10-24 03:59:59 | 0 | 2026-08-24 20:09:23 | 1 | 0 | 09000064b94706ba | |
| FDA-2007-D-0369-2660 | FDA | FDA-2007-D-0369 | PSG_020243 - Draft Guidance on Fluvoxamine Maleate | Other | Guidance | 2026-08-24 | 2026 | 8 | 2026-08-24 | 2026-10-23 | 2026-10-24 03:59:59 | 0 | 2026-08-24 20:09:28 | 1 | 0 | 09000064b94706bc | |
| FDA-2007-D-0369-2661 | FDA | FDA-2007-D-0369 | PSG_020496 - Draft Guidance on Glimepiride | Other | Guidance | 2026-08-24 | 2026 | 8 | 2026-08-24 | 2026-10-23 | 2026-10-24 03:59:59 | 0 | 2026-08-24 20:09:33 | 1 | 0 | 09000064b94706be | |
| FDA-2007-D-0369-2662 | FDA | FDA-2007-D-0369 | PSG_213876 - Draft Guidance on Hydrocortisone | Other | Guidance | 2026-08-24 | 2026 | 8 | 2026-08-24 | 2026-10-23 | 2026-10-24 03:59:59 | 0 | 2026-08-24 20:09:38 | 1 | 0 | 09000064b94706c0 | |
| FDA-2007-D-0369-2663 | FDA | FDA-2007-D-0369 | PSG_206185 - Draft Guidance on Latanoprost | Other | Guidance | 2026-08-24 | 2026 | 8 | 2026-08-24 | 2026-10-23 | 2026-10-24 03:59:59 | 0 | 2026-08-24 20:09:42 | 1 | 0 | 09000064b94706c2 | |
| FDA-2007-D-0369-2664 | FDA | FDA-2007-D-0369 | PSG_209939 - Draft Guidance on Letermovir | Other | Guidance | 2026-08-24 | 2026 | 8 | 2026-08-24 | 2026-10-23 | 2026-10-24 03:59:59 | 0 | 2026-08-24 20:10:09 | 1 | 0 | 09000064b94706c4 | |
| FDA-2007-D-0369-2665 | FDA | FDA-2007-D-0369 | PSG_021343 - Draft Guidance on Leuprolide Acetate | Other | Guidance | 2026-08-24 | 2026 | 8 | 2026-08-24 | 2026-10-23 | 2026-10-24 03:59:59 | 0 | 2026-08-24 20:10:14 | 1 | 0 | 09000064b94706c6 | |
| FDA-2007-D-0369-2666 | FDA | FDA-2007-D-0369 | PSG_021379 - Draft Guidance on Leuprolide Acetate | Other | Guidance | 2026-08-24 | 2026 | 8 | 2026-08-24 | 2026-10-23 | 2026-10-24 03:59:59 | 0 | 2026-08-24 20:10:19 | 1 | 0 | 09000064b94706c8 | |
| FDA-2007-D-0369-2667 | FDA | FDA-2007-D-0369 | PSG_021731 - Draft Guidance on Leuprolide Acetate | Other | Guidance | 2026-08-24 | 2026 | 8 | 2026-08-24 | 2026-10-23 | 2026-10-24 03:59:59 | 0 | 2026-08-24 20:10:24 | 1 | 0 | 09000064b94706ca | |
| FDA-2007-D-0369-2668 | FDA | FDA-2007-D-0369 | PSG_021924 - Draft Guidance on Levothyroxine Sodium | Other | Guidance | 2026-08-24 | 2026 | 8 | 2026-08-24 | 2026-10-23 | 2026-10-24 03:59:59 | 0 | 2026-08-24 20:10:29 | 1 | 0 | 09000064b94706cc | |
| FDA-2007-D-0369-2669 | FDA | FDA-2007-D-0369 | PSG_215029 - Draft Guidance on Lidocaine | Other | Guidance | 2026-08-24 | 2026 | 8 | 2026-08-24 | 2026-10-23 | 2026-10-24 03:59:59 | 0 | 2026-08-24 20:10:35 | 1 | 0 | 09000064b94706ce | |
| FDA-2007-D-0369-2670 | FDA | FDA-2007-D-0369 | PSG_021977 - Draft Guidance on Lisdexamfetamine Dimesylate | Other | Guidance | 2026-08-24 | 2026 | 8 | 2026-08-24 | 2026-10-23 | 2026-10-24 03:59:59 | 0 | 2026-08-24 20:10:41 | 1 | 0 | 09000064b94706d0 | |
| FDA-2007-D-0369-2671 | FDA | FDA-2007-D-0369 | PSG_219847 - Draft Guidance on Lisdexamfetamine Dimesylate | Other | Guidance | 2026-08-24 | 2026 | 8 | 2026-08-24 | 2026-10-23 | 2026-10-24 03:59:59 | 0 | 2026-08-24 20:10:46 | 1 | 0 | 09000064b94706d2 | |
| FDA-2007-D-0369-2672 | FDA | FDA-2007-D-0369 | PSG_219485 - Draft Guidance on Maralixibat Chloride | Other | Guidance | 2026-08-24 | 2026 | 8 | 2026-08-24 | 2026-10-23 | 2026-10-24 03:59:59 | 0 | 2026-08-24 20:10:51 | 1 | 0 | 09000064b94706d4 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW open_comments_active AS SELECT * FROM documents WHERE comment_end_datetime >= datetime('now') AND withdrawn = 0 AND perpetual_docket IS NOT 1;